title: Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop.
abstract: Cyclooxygenase inhibitors, such as indomethacin and diclofenac, have well-described effects to enhance renal water reabsorption and urinary concentrating ability. Concentrating ability is regulated in part at the level of the thick ascending limb of Henle's loop, where active NaCl absorption drives the countercurrent multiplication mechanism. We used semiquantitative immunoblotting to test the effects of indomethacin and diclofenac, given over a 48-h period, on the expression levels of the ion transporters responsible for active NaCl transport in the thick ascending limb. Both agents strongly increased the expression level of the apical Na-K-2Cl cotransporter in both outer medulla and cortex. Neither agent significantly altered outer medullary expression levels of other thick ascending limb proteins, namely, the type 3 Na/H exchanger (NHE-3), Tamm-Horsfall protein, or alpha1- or beta1-subunits of the Na-K-ATPase. Administration of the EP3-selective PGE(2) analog, misoprostol, to indomethacin-treated rats reversed the stimulatory effect of indomethacin on Na-K-2Cl cotransporter expression. We conclude that cyclooxygenase inhibitors enhance urinary concentrating ability in part through effects to increase Na-K-2Cl cotransporter expression in the thick ascending limb of Henle's loop. This action is most likely due to elimination of an EP3-receptor-mediated tonic inhibitory effect of PGE(2) on cAMP production.
authors.affiliation: Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA.
authors.forename: P
authors.initials: P
authors.lastname: Fernández-Llama
authors.forename: C A
authors.initials: CA
authors.lastname: Ecelbarger
authors.forename: J A
authors.initials: JA
authors.lastname: Ware
authors.forename: P
authors.initials: P
authors.lastname: Andrews
authors.forename: A J
authors.initials: AJ
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Turner
authors.forename: S
authors.initials: S
authors.lastname: Nielsen
authors.forename: M A
authors.initials: MA
authors.lastname: Knepper
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004008:Diclofenac / Q000494:pharmacology; D007213:Indomethacin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008138:Loop of Henle / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D016595:Misoprostol / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018078:Receptors, Prostaglandin E / Q000819:agonists; D058308:Receptors, Prostaglandin E, EP3 Subtype; D028021:Sodium-Potassium-Chloride Symporters
chemical_list: D002352:Carrier Proteins; D016861:Cyclooxygenase Inhibitors; D018078:Receptors, Prostaglandin E; D058308:Receptors, Prostaglandin E, EP3 Subtype; D028021:Sodium-Potassium-Chloride Symporters; D016595:Misoprostol; D004008:Diclofenac; D007213:Indomethacin